Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q4 2025 · 147 positions · Total reported value $2.15B · Top-10 concentration 24.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Invenomic Capital Management LP disclosed 147 equity positions with a combined reported value of $2.15B. The filing implies a diversified portfolio: its ten largest positions account for 24.9% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q4 2025 were VTRS ($69.64M), GPN ($61.73M), XRAY ($58.66M). By sector, the heaviest allocations are Consumer Discretionary 30.1%, Technology 17.5%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+6.5pp), Industrials (+3.8pp) and away from Health Care (-1.2pp), Communication Services (-2.4pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q4 2025 were AZO ($54.26M), ORLY ($22.73M), FISV ($19.30M).

Of the 35 positions fully exited versus the prior quarter, the largest were ARKK ($103.56M), SPY ($50.23M), HAE ($24.29M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • AZO AUTOZONE INC · $54.26M
  • ORLY OREILLY AUTOMOTIVE INC · $22.73M
  • FISV FISERV INC · $19.30M
  • OC OWENS CORNING NEW · $18.33M
  • INGR INGREDION INC · $16.69M
  • MOS MOSAIC CO · $16.34M
  • CENTA CENTRAL GARDEN & PET CO · $13.75M
  • ZBH ZIMMER BIOMET HOLDINGS INC · $12.04M

Fully Exited (vs previous quarter)

  • ARKK ARK ETF TR · prev qtr: $103.56M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $50.23M
  • HAE HAEMONETICS CORP MASS · prev qtr: $24.29M
  • BKH BLACK HILLS CORP · prev qtr: $19.61M
  • SEE SEALED AIR CORP NEW COM · prev qtr: $15.49M
  • UHS UNIVERSAL HLTH SVCS INC · prev qtr: $14.98M · history
  • GOLD GOLD COM INC · prev qtr: $13.44M
  • KHC KRAFT HEINZ CO · prev qtr: $12.98M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 17.5%
Health Care 17.1%
Industrials 14.5%
Materials 6.5%
Financials 3.4%
Other 7.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.59M $69.64M 3.24%
3.24%
Add
2 797.50K $61.73M 2.87%
2.87%
Add
3 5.13M $58.66M 2.73%
2.73%
Add
4 671.57K $58.59M 2.73%
2.73%
Add
5 16.00K $54.26M 2.53%
2.53%
New
6 1.50M $53.75M 2.50%
2.50%
Reduce
7 3.31M $47.00M 2.19%
2.19%
Add
8 1.54M $44.42M 2.07%
2.07%
Add
9 652.97K $43.76M 2.04%
2.04%
Add
10 3.03M $42.51M 1.98%
1.98%
Add
11 346.56K $42.29M 1.97%
1.97%
Reduce
12 1.22M $40.53M 1.89%
1.89%
Add
13 708.91K $38.66M 1.80%
1.80%
Add
14 871.44K $38.03M 1.77%
1.77%
Add
15 455.67K $36.80M 1.71%
1.71%
Add
16 874.24K $36.35M 1.69%
1.69%
Add
17 174.51K $35.16M 1.64%
1.64%
Add
18 11.96M $32.65M 1.52%
1.52%
Add
19 9.03M $30.16M 1.40%
1.40%
Add
20 737.55K $29.94M 1.39%
1.39%
Add
21 2.38M $27.27M 1.27%
1.27%
Add
22 2.44M $26.81M 1.25%
1.25%
Add
23 629.45K $26.63M 1.24%
1.24%
Add
24 331.17K $24.41M 1.14%
1.14%
Hold
25 1.60M $23.95M 1.11%
1.11%
Add
26 404.62K $23.62M 1.10%
1.10%
Add
27 1.09M $23.27M 1.08%
1.08%
Add
28 249.20K $22.73M 1.06%
1.06%
New
29 1.54M $22.64M 1.05%
1.05%
Reduce
30 1.44M $22.04M 1.03%
1.03%
Add
31 1.68M $20.96M 0.97%
0.97%
Add
32 1.72M $20.89M 0.97%
0.97%
Add
33 1.05M $20.29M 0.94%
0.94%
Reduce
34 756.72K $20.16M 0.94%
0.94%
Add
35 1.40M $20.10M 0.94%
0.94%
Add
36 557.61K $19.60M 0.91%
0.91%
Add
37 386.05K $19.57M 0.91%
0.91%
Add
38 287.27K $19.30M 0.90%
0.90%
New
39 1.91M $18.55M 0.86%
0.86%
Hold
40 2.13M $18.47M 0.86%
0.86%
Hold
41 197.76K $18.33M 0.85%
0.85%
Hold
42 163.76K $18.33M 0.85%
0.85%
New
43 607.80K $17.85M 0.83%
0.83%
Add
44 277.22K $17.70M 0.82%
0.82%
Add
45 258.34K $17.17M 0.80%
0.80%
Add
46 151.38K $16.69M 0.78%
0.78%
New
47 653.51K $16.44M 0.77%
0.77%
Add
48 678.23K $16.34M 0.76%
0.76%
New
49 1.59M $15.76M 0.73%
0.73%
Add
50 735.10K $14.57M 0.68%
0.68%
Reduce

FAQ

What did Invenomic Capital Management LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Invenomic Capital Management LP reported 147 equity positions worth $2.15B in aggregate; its largest disclosed positions were VTRS ($69.64M), GPN ($61.73M), XRAY ($58.66M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.15B of long equity holdings across 147 positions as of 2025-Q4. Top-10 holdings account for 24.9% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →